Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi (CONDA-YAPA)

This study has been completed.
Sponsor:
Collaborators:
University of Malawi College of Medicine
London School of Hygiene and Tropical Medicine
Ministry of Health and Population, Malawi
Information provided by (Responsible Party):
Liverpool School of Tropical Medicine
ClinicalTrials.gov Identifier:
NCT01414413
First received: August 10, 2011
Last updated: February 19, 2014
Last verified: February 2014

August 10, 2011
February 19, 2014
January 2012
November 2012   (final data collection date for primary outcome measure)
ART Initiation [ Time Frame: First six months following introduction of home-based HIV testing ] [ Designated as safety issue: No ]
Comparison between study arms of the proportion of all resident adults (per capita, and irrespective of HIV status or participation in home-based HIV testing intervention) who initiate ART during the first 6 months of the home-based HIV-testing intervention.
Same as current
Complete list of historical versions of study NCT01414413 on ClinicalTrials.gov Archive Site
  • Uptake of Home-based HIV Testing [ Time Frame: The first 6-months following home assessment and initiation of ART being made available ] [ Designated as safety issue: No ]
    Comparison between study arms of the proportion of all resident adults who request HIV testing (either as standard HTC or as supervised HIV self-testing) from the resident community counsellor during the first year of the study.
  • Reporting of HIV-positive Results [ Time Frame: The first 6-months following availability of home-based HIV testing ] [ Designated as safety issue: No ]
    Comparison of the proportion of all cluster adults confiding HIV-positive results to the resident community counsellor between study arms during the 1-year study period
  • Loss to Retention [ Time Frame: The first 6-months following availability of home-based HIV testing ] [ Designated as safety issue: No ]
    Comparison between study arms of the proportion of participants who initiate ART during the first 6-months of the HIV-testing intervention who are lost to retention within 6 months after initiating ART 6-months
  • Adherence to ART [ Time Frame: First 6-months following availability of home-based HIV testing ] [ Designated as safety issue: No ]
    Comparison between study arms of the proportion of HIV-positive participants who are adherent to ART during the 1-year study period
  • Adult Mortality [ Time Frame: The first 6-months following availability of home-based HIV testing ] [ Designated as safety issue: No ]
    Comparison between study arms of non-traumatic and HIV-related adult (15-49) mortality rates during the first 6 months of the HIV-testing intervention
  • Uptake of home-based HIV testing [ Time Frame: The first 6-months following home assessment and initiation of ART being made available ] [ Designated as safety issue: No ]
    Comparison between study arms of the proportion of all resident adults who request HIV testing (either as standard HTC or as supervised HIV self-testing) from the resident community counsellor during the first year of the study.
  • Disclosure of HIV-positive results [ Time Frame: The first 6-months following availability of home-based HIV testing ] [ Designated as safety issue: No ]
    Comparison of the proportion of all cluster adults confiding HIV-positive results to the resident community counsellor between study arms during the 1-year study period
  • Retention on ART [ Time Frame: The first 6-months following availability of home-based HIV testing ] [ Designated as safety issue: No ]
    Comparison between study arms of the proportion of participants who initiate ART during the first 6-months of the HIV-testing intervention who are retained on ART 6-months after initiation
  • Adherence to ART [ Time Frame: First 6-months following availability of home-based HIV testing ] [ Designated as safety issue: No ]
    Comparison between study arms of the proportion of HIV-positive participants who are adherent to ART during the 1-year study period
  • Adult mortality [ Time Frame: The first 6-months following availability of home-based HIV testing ] [ Designated as safety issue: No ]
    Comparison between study arms of non-traumatic and HIV-related adult (15-49) mortality rates during the first 6 months of the HIV-testing intervention
Not Provided
Not Provided
 
Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi
Home Assessment and Initiation of ART: a Cluster-randomised Trial in Blantyre, Malawi

Despite increasing availability of antiretroviral therapy (ART) for HIV in high prevalence countries, the majority of people with HIV infection still initiate treatment at an advanced stage of disease. This leads to a high risk of death soon after HIV diagnosis. Prompt HIV diagnosis is, therefore, necessary for both individual and public health benefit and is being strongly promoted as international and national policy in Malawi. However timely HIV diagnosis may not in itself be sufficient to ensure ART initiation: this is reflected by the relatively high proportion of individuals who defer treatment-seeking for months or years following diagnosis of HIV.

Here the researchers investigate the extent to which home assessment and initiation of ART adds to the effectiveness of a home-based HIV testing and counseling strategy, using entry to, adherence with, and retention in HIV care as the outcome of interest.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
HIV
  • Other: Home assessment and initiation of ART
    Home-based ART eligibility assessment (WHO staging, CD4 count measurement and educational treatment preparation) and initiation.
  • Other: Clinic-based ART assessment and initiation
    Participants who meet eligibility criteria and reside in a cluster that has been allocated to the control arm of this study will receive supported access to ART care through the primary care system for confirmation of HIV status and entry into HIV following disclosure to the resident community counsellor.
  • Experimental: Home assessment and initiation of ART

    Participants with a positive home-based HIV test result will receive a home visit from a study nurse who will complete the following on the first home visit:

    • Confirmatory fingerprick HIV testing
    • TB symptom screening
    • ART eligibility assessment (Word Health Organization clinical staging, sampling of blood for measurement of CD4 count and treatment education)

    At a second home visit (within 5 days), participants who are ART eligible (as defined in National ART guidelines) will be initiated onto ART (using National Treatment Programme ART regimens).

    Following home initiation of ART, participants in the intervention arm will receive detailed counselling from the study nurse about the need to attend their first 2-week follow-up appointment at the primary health care clinic that serves their household's residence. They will receive a referral slip detailing the date, time and place of their appointment.

    Intervention: Other: Home assessment and initiation of ART
  • Clinic-based ART assessment and initiation
    Participants who meet eligibility criteria and reside in a cluster that has been allocated to the control arm of this study will receive supported access to ART care through the primary care system for confirmation of HIV status and entry into HIV following disclosure to the resident community counsellor. HIV care, including ART, will be started from the primary care clinic.
    Intervention: Other: Clinic-based ART assessment and initiation
MacPherson P, Lalloo DG, Webb EL, Maheswaran H, Choko AT, Makombe SD, Butterworth AE, van Oosterhout JJ, Desmond N, Thindwa D, Squire SB, Hayes RJ, Corbett EL. Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. JAMA. 2014 Jul 23-30;312(4):372-9. doi: 10.1001/jama.2014.6493.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16660
April 2013
November 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Usual resident of an eligible cluster
  • Has had a positive HIV test (regardless of source) and requests facilitated access to HIV care from the resident community counsellor
  • Confirmatory HIV test is positive
  • No previous ART treatment, or less than one month's treatment in the past (including PMTCT interventions) and not currently receiving HIV care
  • No contraindications to receiving ART (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO)
  • No acute danger signs requiring hospital referral
  • Aged 18 years or older
  • Written or witnessed informed consent to participate in the study

Exclusion Criteria:

  • Not a usual resident of an eligible cluster
  • No previous HIV test, or HIV infection not confirmed by home-based ART nurse
  • Already receiving ART, or has had more than 1 month's treatment in the past
  • Known contraindication to firstline ART (known hypersensitivity, renal failure, chronic liver disease)
  • Acute danger sign present (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO)
  • Age younger than 18 years
  • Not willing to accept home-based ART initiation
  • Suspected or confirmed TB disease will not be an exclusion criteria, but will be an indication for deferral, until completion of the screening algorithm, with initiation of TB treatment if indicated.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Malawi
 
NCT01414413
MLW-089673, WT089673/B/09/Z
No
Liverpool School of Tropical Medicine
Liverpool School of Tropical Medicine
  • University of Malawi College of Medicine
  • London School of Hygiene and Tropical Medicine
  • Ministry of Health and Population, Malawi
Principal Investigator: Peter MacPherson, MBChCB MPH Liverpool School of Tropical Medicine
Liverpool School of Tropical Medicine
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP